| Literature DB >> 24210817 |
Jeroen Pouwels1,2, Nicola De Franceschi1,2, Marko Salmi3,4,5, Johanna Ivaska1,2,6, Pia Rantakari3, Kaisa Auvinen3,5, Marika Karikoski3, Elina Mattila1, Christopher Potter7, John P Sundberg7, Nancy Hogg8, Carl G Gahmberg9.
Abstract
SHARPIN-deficient mice display a multiorgan chronic inflammatory phenotype suggestive of altered leukocyte migration. We therefore studied the role of SHARPIN in lymphocyte adhesion, polarization, and migration. We found that SHARPIN localizes to the trailing edges (uropods) of both mouse and human chemokine-activated lymphocytes migrating on intercellular adhesion molecule-1 (ICAM-1), which is one of the major endothelial ligands for migrating leukocytes. SHARPIN-deficient cells adhere better to ICAM-1 and show highly elongated tails when migrating. The increased tail lifetime in SHARPIN-deficient lymphocytes decreases the migration velocity. The adhesion, migration, and uropod defects in SHARPIN-deficient lymphocytes were rescued by reintroducing SHARPIN into the cells. Mechanistically, we show that SHARPIN interacts directly with lymphocyte-function-associated antigen-1 (LFA-1), a leukocyte counterreceptor for ICAM-1, and inhibits the expression of intermediate and high-affinity forms of LFA-1. Thus, SHARPIN controls lymphocyte migration by endogenously maintaining LFA-1 inactive to allow adjustable detachment of the uropods in polarized cells.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24210817 PMCID: PMC3852511 DOI: 10.1016/j.celrep.2013.10.011
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423